.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Vortrag
MSV 091

Development of resistance to Ceftazidime/Avibactam in bla_OXA244-carrying Escherichia coli during therapy, associated with mutations in acrB and mrdA

Termin

Datum: 19.09.2023

Zeit: 15:15 – 15:30

Redezeit: 10 Min.

Diskussionszeit: 5 Min.

Ort / Stream:

Seminarraum 2

Session

Molecular Infection Epidemiology and Prediction of Antimicrobial Resistance 2 (FG MS)

Thema

Molecular Infection Epidemiology and Prediction of Antimicrobial Resistance (FG MS)

Mitwirkende

Kaan Koçer (Heidelberg, DE), Niklas Weidner (Heidelberg, DE)

Development of resistance to Ceftazidime/Avibactam in blaOXA244-carrying Escherichia coli during therapy, associated with mutations in acrB and mrdA

Termin

Session

Thema

Mitwirkende

Development of resistance to Ceftazidime/Avibactam in bla_OXA244-carrying Escherichia coli during therapy, associated with mutations in acrB and mrdA